|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Methyldopa#How Supplied]] |
| {{Methyldopa}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==How Supplied:==
| |
| | |
| Methyldopa Tablets, USP are supplied as film-coated tablets containing either 250 mg or 500 mg of Methyldopa, USP.
| |
| | |
| The 250 mg tablets are beige, film-coated, round, unscored tablets debossed with MYLAN on one side of the tablet and 611 on the other side. They are available as follows:
| |
| | |
| NDC 51079-200-20 - Unit dose blister packages of 100 (10 cards of 10 tablets each).
| |
| | |
| The 500 mg tablets are beige, film-coated, capsule-shaped, unscored tablets debossed with MYLAN on one side of the tablet and 421 on the other side. They are available as follows:
| |
| | |
| NDC 51079-201-20 - Unit dose blister packages of 100 (10 cards of 10 tablets each).
| |
| | |
| Store at 20° to 25°C (68° to 77°F). [See USP for Controlled Room Temperature.]
| |
| Protect from light.
| |
| | |
| Manufactured by:
| |
| Mylan Pharmaceuticals Inc.
| |
| Morgantown, WV 26505
| |
| | |
| Packaged and Distributed by:
| |
| UDL Laboratories, Inc.
| |
| Rockford, IL 61103
| |
| | |
| S-9014 R2
| |
| 1/07<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METHYLDOPA TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d87d63fd-48f7-4130-af03-5e263c338fe4 | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |